275 related articles for article (PubMed ID: 28415658)
21. Prognostic significance of neutrophil-lymphocyteratio/platelet-lymphocyteratioin lung cancers: a meta-analysis.
Yang HB; Xing M; Ma LN; Feng LX; Yu Z
Oncotarget; 2016 Nov; 7(47):76769-76778. PubMed ID: 27732958
[TBL] [Abstract][Full Text] [Related]
22. The diagnostic value of circulating tumor cells for lung cancer: A systematic review and meta-analysis.
Ye Y; Li SL; Wang JJ; Liu B
Medicine (Baltimore); 2019 Mar; 98(12):e14936. PubMed ID: 30896658
[TBL] [Abstract][Full Text] [Related]
23. Serum pro-gastrin-releasing peptide in diagnosis of small cell lung cancer: A meta-analysis.
Wang H; Qian J
J Cancer Res Ther; 2016 Dec; 12(Supplement):C260-C263. PubMed ID: 28230031
[TBL] [Abstract][Full Text] [Related]
24. The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis.
Cui C; Sun X; Zhang J; Han D; Gu J
J Cancer Res Ther; 2014 Nov; 10 Suppl():C131-4. PubMed ID: 25450270
[TBL] [Abstract][Full Text] [Related]
25. The value of miR-155 as a biomarker for the diagnosis and prognosis of lung cancer: a systematic review with meta-analysis.
Shao C; Yang F; Qin Z; Jing X; Shu Y; Shen H
BMC Cancer; 2019 Nov; 19(1):1103. PubMed ID: 31727002
[TBL] [Abstract][Full Text] [Related]
26. Pooling-analysis for diagnostic and prognostic value of MiRNA-100 in various cancers.
Dou Z; Lin S; Dai C; Lu Y; Tian T; Wang M; Liu X; Zheng Y; Xu P; Li S; Sheng Q; Deng Y; Dai Z
Oncotarget; 2017 Sep; 8(37):62703-62715. PubMed ID: 28977982
[TBL] [Abstract][Full Text] [Related]
27. Circulating tumor DNA is effective for the detection of EGFR mutation in non-small cell lung cancer: a meta-analysis.
Qiu M; Wang J; Xu Y; Ding X; Li M; Jiang F; Xu L; Yin R
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):206-12. PubMed ID: 25339418
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic Accuracy of PIK3CA Mutation Detection by Circulating Free DNA in Breast Cancer: A Meta-Analysis of Diagnostic Test Accuracy.
Zhou Y; Wang C; Zhu H; Lin Y; Pan B; Zhang X; Huang X; Xu Q; Xu Y; Sun Q
PLoS One; 2016; 11(6):e0158143. PubMed ID: 27336598
[TBL] [Abstract][Full Text] [Related]
29. Clinical utility of microRNA-378 as early diagnostic biomarker of human cancers: a meta-analysis of diagnostic test.
Li ZZ; Shen LF; Li YY; Chen P; Chen LZ
Oncotarget; 2016 Sep; 7(36):58569-58578. PubMed ID: 27448977
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of circulating miR-155 for breast cancer: a meta-analysis.
Wang F; Wang J; Zhang H; Fu B; Zhang Y; Jia Q; Wang Y
Front Oncol; 2024; 14():1374674. PubMed ID: 38590648
[TBL] [Abstract][Full Text] [Related]
31. Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer.
Ai B; Liu H; Huang Y; Peng P
Oncotarget; 2016 Jul; 7(28):44583-44595. PubMed ID: 27323821
[TBL] [Abstract][Full Text] [Related]
32. The diagnostic accuracy of HE4 in lung cancer: a meta-analysis.
Cheng D; Sun Y; He H
Dis Markers; 2015; 2015():352670. PubMed ID: 25873748
[TBL] [Abstract][Full Text] [Related]
33. The efficacy of first-line chemotherapy is associated with KRAS mutation status in patients with advanced non-small cell lung cancer: a meta-analysis.
Zhang Y; Fang W; Yan Y; Wang M; Kang S; Sheng J; Zhan J; Chen N; Hong S; Yang Y; Ma Y; He D; Qin T; Zhou T; Tang Y; He X; Liang W; Zhang L
Med Oncol; 2015 Mar; 32(3):61. PubMed ID: 25663066
[TBL] [Abstract][Full Text] [Related]
34. Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2).
Cadranel J; Mauguen A; Faller M; Zalcman G; Buisine MP; Westeel V; Longchampt E; Wislez M; Coudert B; Daniel C; Chetaille B; Michiels S; Blons H; Solassol J; De Fraipont F; Foucher P; Urban T; Lacroix L; Poulot V; Quoix E; Antoine M; Danton G; Morin F; Chouaid C; Pignon JP
J Thorac Oncol; 2012 Oct; 7(10):1490-502. PubMed ID: 22982650
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic and prognostic value of circulating tumor DNA in gastric cancer: a meta-analysis.
Gao Y; Zhang K; Xi H; Cai A; Wu X; Cui J; Li J; Qiao Z; Wei B; Chen L
Oncotarget; 2017 Jan; 8(4):6330-6340. PubMed ID: 28009985
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic accuracy of radiology (CT, X-ray, US) for predicting difficult intubation in adults: A meta-analysis.
Ji C; Ni Q; Chen W
J Clin Anesth; 2018 Mar; 45():79-87. PubMed ID: 29306118
[TBL] [Abstract][Full Text] [Related]
37. K-Ras mutation detection in liquid biopsy and tumor tissue as prognostic biomarker in patients with pancreatic cancer: a systematic review with meta-analysis.
Li T; Zheng Y; Sun H; Zhuang R; Liu J; Liu T; Cai W
Med Oncol; 2016 Jul; 33(7):61. PubMed ID: 27225938
[TBL] [Abstract][Full Text] [Related]
38. Reliability of digital PCR in detecting KRAS mutation in colorectal cancer using plasma sample: A systematic review and meta-analysis.
Ye P; Cai P; Xie J; Zhang J
Medicine (Baltimore); 2020 Jul; 99(28):e21171. PubMed ID: 32664155
[TBL] [Abstract][Full Text] [Related]
39. The Potential Diagnostic Accuracy of Let-7 Family for Cancer: A Meta-Analysis.
Zhang WT; Zhang GX; Gao SS
Technol Cancer Res Treat; 2021; 20():15330338211033061. PubMed ID: 34259101
[TBL] [Abstract][Full Text] [Related]
40. Association Between Computed Tomographic Features and Kirsten Rat Sarcoma Viral Oncogene Mutations in Patients With Stage I Lung Adenocarcinoma and Their Prognostic Value.
Wang H; Schabath MB; Liu Y; Stringfield O; Balagurunathan Y; Heine JJ; Eschrich SA; Ye Z; Gillies RJ
Clin Lung Cancer; 2016 Jul; 17(4):271-8. PubMed ID: 26712103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
